Chemical inhibition of the AKT pathway using the non‐selective PI3K inhibitor LY‐294002, but not ERK pathway inhibition, has been reported to protect from insulin resistance both in vitro and in vivo.67, 68. The gene discussed is AKT1; the disease is Insulin resistance.